29 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
the lifecycle of its approved medicines, EGRIFTA SV® and Trogarzo® in HIV.
Lifecycle Management of Tesamorelin in Lipodystrophy
F8 Formulation
On September … Formulation could be used in our proposed Phase 2b/3 clinical trial studying tesamorelin for the treatment of NASH in the general population.
Lifecycle
SUPPL
THTX
Theratechnologies Inc.
26 Oct 23
Supplemental materials (foreign)
9:13pm
and Non-Alcoolic Steato Hepatitis will be made through partnership deals. With the completion of major lifecycle management projects in HIV … opportunities.
Lifecycle Management of Commercial Products
F8 Formulation of Tesamorelin
On September 25, 2023, the Corporation announced that it filed
SUPPL
THTX
Theratechnologies Inc.
25 Oct 23
Supplemental materials (foreign)
6:56pm
Hepatitis will be made through partnership deals. With the completion of major lifecycle management projects in HIV, the Corporation’s medical … capabilities will remain key to conveying the science behind its products and achieving business growth from organic and inorganic opportunities.
Lifecycle
6-K
EX-99.1
THTX
Theratechnologies Inc.
24 Oct 23
Material Change Report
2:46pm
deals. With the completion of major lifecycle management projects in HIV, the Company’s medical capabilities remain key to conveying the science
6-K
EX-99.1
9kq 98152evxiy
24 Oct 23
Theratechnologies Announces Operational Update
8:24am
6-K
EX-99.1
kss6gmu4jmsgnn
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.2
dya6c5cr85dskrdvxo
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
oq1k3 1kf
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.2
a8o3mxmpitkv1
13 Apr 23
Notice of Annual Meeting of Shareholders
8:01am
6-K
EX-99.2
cs4xo6m20zg
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
j04kgqkw7 y1ar1
12 Apr 23
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
7:45am
6-K
EX-99.2
2oem06jsz
13 Oct 22
Interim Consolidated Financial Statements
8:01am
6-K
EX-99.1
7xy9fc4yuf0yy
13 Oct 22
Theratechnologies Reports Financial Results
7:45am
6-K
EX-99.2
0efv7u6jewvk9h2
14 Jul 22
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
7juhj eke9x6jg
14 Jul 22
Theratechnologies Reports Second Quarter and First Half
7:45am
6-K
EX-99.2
9a644k
13 Apr 22
Interim Consolidated Financial Statements
7:45am
6-K
EX-99.1
4rlp iwjym6lm
13 Apr 22
Theratechnologies Reports Financial Results
7:30am
6-K
EX-99.1
zbbqc
24 Feb 22
Theratechnologies Reports Financial Results
7:30am
6-K
EX-99.2
kjfeap64
13 Oct 21
Interim Consolidated Financial Statements
8:00am